Escrow Watch
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Island Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Imugene levels up in Phase 1 trial, Imricor slides into Greece
Health & Biotech
ASX Health Stocks: Pharmaxis jumps 9pc on FDA approval
Health & Biotech
ASX health stocks: CSL leads another round of strong earnings, but FY22 outlook remains subdued
Health & Biotech
Dr Boreham’s Crucible: Who’s winning and losing in the life sciences IPO Olympiad?
Health & Biotech
ASX Health Stocks: Chimeric gets licence for CAR-T from U-Pen, Acrux gets nod from the FDA
Health & Biotech
ASX health stocks: Proteomics jumps 10% on blood test deal with Nasdaq-listed Abcam
IPO Watch
IPO Watch: Which sector has provided the best performing IPOs in 2021?
Health & Biotech
Dr Boreham’s Crucible: Can Island Pharmaceuticals build the ultimate mozzie-zapper?
IPO Watch
IPO Watch: 3 IPOs have sparked the week, but health and tech stocks still outperform
News
Rise and Shine: What you need to know before the ASX opens
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
Last Orders: ASX finishes slightly in the green; tech gains 2 per cent & another IPO more than doubles
News
ASX Small Cap Lunch Wrap: Tech continues its winning ways
IPO Watch
IPO Watch: Mosquito disease fighter Island Pharmaceuticals doubles on debut
IPO Watch